HUINNO is a digital healthcare company committed to research and development of services and solutions for the early diagnosis of cardiovascular disease, the leading cause of death across the globe.
Our original wearable devices are designed to monitor crucial biosignals and employ AI-based algorithms to provide a rapid and precise analysis, helping providers make more informed decisions and diagnoses.
We continue to produce meaningful solutions for both patients and medical professionals.
Memo Band obtained MFDS medical device item approval.
Obtained insurance reimbursement code for remote heart monitoring technology (EX871)
Selected as an Excellent Work-Life Balance Company in Korea
Selected as a Family-Friendly Certified Company
Received the Minister of Science and ICT Award at the Korea Invention Patent Exhibition
Acquired certifications for ISO 27001 / ISO 27701 / HIPAA (Information Security Management Systems)
Receives an award from the Minister of Health and
Welfare for Korea Medical Devices Industry Association
at the regular general meeting merit awards
Enters into an ECG analysis MOU with Bucheon Sejong Hospital
Establishes KHAIM, a joint venture with Korea University Holdings
Receives award from the Minister of Health and Welfare for
contributing to the health and medical service technology business
Selected to present at the J.P. Morgan Healthcare Conference,
Global IR @JPM
Receives seed funding for HUINNO AIM (4 billion KRW)
Selected as a usability assessment company with
the Ministry of Food and Drug Safety’s recently adopted
international standards for the latest medical devices
Enters into a data-driven arrhythmia diagnosis and
treatment MOU with Johnson & Johnson Medical Korea
Selected as a representative company for
the biohealth sector regulation and innovation meeting by
Ministry of Health and Welfare
Enters into a domestic copyright agreement for
MEMO Patch with Yuhan Corporation
Receives Best Companies Award at
the Health 2.0 Conference in Dubai
Founds subsidiary HUINNO AIM
Selected as an outstanding 2021 R&D business by
Seoul Business Agency
Secures Series C Funding (43.5 billion KRW)
Ranks 2nd among all-lead ECG devices and
1st place for 6 & 4 lead ECG at
the Global AI Challenge, PhysioNet
Selected as a Top 20 MedTech Innovator Asia-Pacific company
Acquires a production license for
the MEMO Patch medical device
Enters into an arrhythmia diagnosis and
treatment MOU with Johnson & Johnson Medical Korea
Headquarters relocates
(from Seoul Biohub in Hoegi-dong, Dongdaemun-gu District,
to Cheongdam-dong, Gangnam-gu District)
MEMO Patch receives reimbursement from
the Health Insurance Review and Assessment Service
as a wearable ECG device
Enters into a listed lead manager agreement with
NH Investment & Securities
Receives MEMO Watch CE certification
MEMO Patch receives the first u-Healthcare ECG certification
in Korea from the Ministry of Food and Drug Safety
Secures Series B funding (20 billion KRW)
Receives an award from the Minister of Science and ICT
at the ICT Innovation Awards
MEMO Watch becomes the first wearable ECG device in
Korea to receive reimbursement from
the Health Insurance Review and Assessment Service
Clinical trials start for remote monitoring with MEMO Watch,
the first wearable ECG device in Korea
Ranks 2nd in the creativity and innovation category
at the LINA Foundation’s 50+ Awards
Receives strategic funding from Yuhan Corporation
(5 billion KRW)
Secures Series A funding (8.4 billion KRW)
First wearable ECG device in Korea to receive
certification from the Ministry of Food and Drug Safety
Selected as the first company in the ICT fusion category
for the regulatory sandbox in Korea
Selected as a partner company of
the Korea Institute of Industrial Technology
Selected for Next Generation Medical Device 100
Project Mentoring by the Ministry of Food and Drug Safety
Receives an award from the Minister of Science and
ICT at the pitching contest for ICT venture funding
Awarded grand prize at the Seoul Innovation Challenge
held by the Seoul Business Agency
Selected as a member of the K-Global 300
by the Ministry of Science, ICT and Future Planning
Ranks 1st place at K Global @ Silicon Valley 2015
Selected as the Korean representative for
the ERA Program in New York, USA (KOTRA)
Selected for the promising ICT development
and support program by the Ministry of Science,
ICT and Future Planning
Selected as a patent star company by
the Seongnam Municipal Government in
Gyeonggi-do Province
HUINNO is founded
CEO / Founder
Pusan National Univ. Ph.D. in Computer Science & Engineering
COO / Deputy CEO
Seoul National Univ. B.A. in French
CTO / Deputy CEO
Pusan National Univ. Ph.D. in Computer Science & Engineering
CRIO / Technical Director
Pusan National Univ. Ph.D. in Computer Science & Engineering
Total investment amounts to 80 billion KRW. Series C funding has now been secured.